Universal-Beteiligungs- und Servicegesellschaft’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Hold
808,700
– – ﹤0.01% 1445
2026
Q1
$1.07M Hold
808,700
– – ﹤0.01% 1486
2025
Q4
$1.4M Hold
808,700
– – ﹤0.01% 1387
2025
Q3
$1.04M Buy
808,700
+400,000
+98% +$542K ﹤0.01% 1536
2025
Q2
$507K Hold
408,700
– – ﹤0.01% 1679
2025
Q1
$482K Buy
+408,700
New +$627K ﹤0.01% 1654

Other funds holding PACB

Universal-Beteiligungs- und Servicegesellschaft's PACB Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft held its Pacific Biosciences (PACB) position steady in Q2 2026 at 808,700 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1445.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in PACB in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.4M in Q4 2025. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 808,700 shares of Pacific Biosciences worth $1.36M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft left its Pacific Biosciences share count unchanged in Q2 2026.
  • Pacific Biosciences made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1445 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Pacific Biosciences in Q1 2025 and has held it in 6 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Pacific Biosciences position peaked at $1.4M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.